Cargando…
Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy
Gamma delta T cells (γδT) are potent mediators of antitumor cytotoxicity and have shown promising efficacy in early phase clinical trials. Most is known about the tumoricidal properties of cells bearing the Vδ2 T cell receptor chain, but recent studies have demonstrated that cells with the Vδ1 chain...
Autores principales: | Fisher, Jonathan, Kramer, Anne-Marijn, Gustafsson, Kenth, Anderson, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404791/ https://www.ncbi.nlm.nih.gov/pubmed/25949890 http://dx.doi.org/10.4161/2162402X.2014.973808 |
Ejemplares similares
-
Anti-leukemia activity of human gamma delta T cells
por: Siegers, Gabrielle M.
Publicado: (2012) -
Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses
por: Anderson, John, et al.
Publicado: (2012) -
Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy
por: Fisher, Jonathan, et al.
Publicado: (2018) -
Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications
por: Gustafsson, Kenth, et al.
Publicado: (2020) -
Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections
por: von Massow, Georg, et al.
Publicado: (2021)